Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$7.94 USD
-0.07 (-0.87%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $7.95 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Average Brokerage Rating
Current ABR | 2.20 |
ABR (Last week) | 2.20 |
# of Recs in ABR | 5 |
Average Target Price | $13.20 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 84 of 253 |
Current Quarter EPS Est: | -0.10 |
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.20 | 2.20 | 2.20 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | H.C. Wainwright & Co. | Douglas Tsao | Strong Buy | Strong Buy |
8/6/2024 | Cowen & Co. | Marc Frahm | Hold | Hold |
8/6/2024 | SVB Securities | David Risinger | Strong Buy | Hold |
8/6/2024 | Evercore Partners | Liisa A Bayko | Hold | Hold |
4/12/2024 | BTIG | Julian Harrison | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.